True North Therapeutics gets $40M new approach to autoimmune disease
Since 2014, True North Therapeutics has raised $97 million for its unique approach to autoimmune disease. Its initial clinical work treats a rare anemia.
Since 2014, True North Therapeutics has raised $97 million for its unique approach to autoimmune disease. Its initial clinical work treats a rare anemia.